Present Evidence of Determinants to Predict the Efficacy of Renal Denervation

Sympathetic overactivation is one of the main contributors to development and progress of hypertension. Renal denervation (RDN) has been evidenced by series of clinical trials for its efficacy and safety to treat overactivated sympathetic nervous system induced diseases. However, the results were in...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hypertension 2022-08, Vol.2022, p.1-12
Main Authors: Zhou, Hao, Xu, Yanping, Chen, Weijie, Wang, Liang, Du, Huaan, Liu, Hang, Ling, Zhiyu, Yin, Yuehui
Format: Article
Language:English
Subjects:
African Americans
Age
Analysis
Antihypertensive drugs
Antihypertensives
Blood pressure
Catheters
Clinical trials
Denervation
Heart rate
Hypertension
Nervous system
Obesity
Patient compliance
Patients
Review
Trends
Ultrasonic imaging
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c519t-a44747b5e152a3a3731cc76ced2133889fb62011013952dbe1ecdd59409fa8e53
cites cdi_FETCH-LOGICAL-c519t-a44747b5e152a3a3731cc76ced2133889fb62011013952dbe1ecdd59409fa8e53
container_end_page 12
container_issue
container_start_page 1
container_title International journal of hypertension
container_volume 2022
creator Zhou, Hao
Xu, Yanping
Chen, Weijie
Wang, Liang
Du, Huaan
Liu, Hang
Ling, Zhiyu
Yin, Yuehui
description Sympathetic overactivation is one of the main contributors to development and progress of hypertension. Renal denervation (RDN) has been evidenced by series of clinical trials for its efficacy and safety to treat overactivated sympathetic nervous system induced diseases. However, the results were inconsistent and not all patients benefited from RDN. Appropriate patient selection and intraoperative factors to improve the efficacy of RDN need to be solved urgently. Over the decade, research studies on the correlations between indicators and the antihypertensive effects have been conducted and made a fairly well progress. Herein, we comprehensively reviewed the research studies on how to make RDN more predictable or improve the efficacy of RDN and summarized these potential indicators or devices which might be applied in clinical settings.
doi_str_mv 10.1155/2022/5694127
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c40c248f9628478ab0a6b7ef44070d7f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A714593137</galeid><doaj_id>oai_doaj_org_article_c40c248f9628478ab0a6b7ef44070d7f</doaj_id><sourcerecordid>A714593137</sourcerecordid><originalsourceid>FETCH-LOGICAL-c519t-a44747b5e152a3a3731cc76ced2133889fb62011013952dbe1ecdd59409fa8e53</originalsourceid><addsrcrecordid>eNp9kl1rFDEUhgdRbFl75w8YEETQbfM5mdwIpa5aqCii1yGTnOxmmU1qkl3pvzfTXaorYhJIOHnOG86b0zTPMTrHmPMLggi54J1kmIhHzSlBEs0RleTxw7lnJ81ZzmtUB5V19U-bE8qlJATR0-bTlwQZQmkXO28hGGija99BgbTxQYeS2xLbylhvSltW0C6c80abu4n7CkGPlQ6Qdrr4GJ41T5weM5wd9lnz_f3i29XH-c3nD9dXlzdzw7Esc82YYGLggDnRVFNBsTGiM2AJprTvpRs6gjBGmEpO7AAYjLVcMiSd7oHTWXO917VRr9Vt8hud7lTUXt0HYloqnYo3IyjDkCGsd7IjPRO9HpDuBgGOMSSQFa5qvd1r3W6HDVhTzUh6PBI9vgl-pZZxpySVGEtaBV4dBFL8sYVc1MZnA-OoA8RtVkQgXutgrK_oi7_QddymauI9xQTvBOO_qaWuBfjgYn3XTKLqUmDGJcXVsllz_g-qTgsbb2IA52v8KOHlHwkr0GNZ5Thup4_Lx-CbPWhSzDmBezADIzW1nZraTh3aruKv9_jKB6t_-v_TvwDNr9D0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2704756745</pqid></control><display><type>article</type><title>Present Evidence of Determinants to Predict the Efficacy of Renal Denervation</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Zhou, Hao ; Xu, Yanping ; Chen, Weijie ; Wang, Liang ; Du, Huaan ; Liu, Hang ; Ling, Zhiyu ; Yin, Yuehui</creator><contributor>Elia, Lanfranco D. ; Lanfranco D Elia</contributor><creatorcontrib>Zhou, Hao ; Xu, Yanping ; Chen, Weijie ; Wang, Liang ; Du, Huaan ; Liu, Hang ; Ling, Zhiyu ; Yin, Yuehui ; Elia, Lanfranco D. ; Lanfranco D Elia</creatorcontrib><description>Sympathetic overactivation is one of the main contributors to development and progress of hypertension. Renal denervation (RDN) has been evidenced by series of clinical trials for its efficacy and safety to treat overactivated sympathetic nervous system induced diseases. However, the results were inconsistent and not all patients benefited from RDN. Appropriate patient selection and intraoperative factors to improve the efficacy of RDN need to be solved urgently. Over the decade, research studies on the correlations between indicators and the antihypertensive effects have been conducted and made a fairly well progress. Herein, we comprehensively reviewed the research studies on how to make RDN more predictable or improve the efficacy of RDN and summarized these potential indicators or devices which might be applied in clinical settings.</description><identifier>ISSN: 2090-0384</identifier><identifier>ISSN: 2090-0392</identifier><identifier>EISSN: 2090-0392</identifier><identifier>DOI: 10.1155/2022/5694127</identifier><identifier>PMID: 35992203</identifier><language>eng</language><publisher>New York: Hindawi</publisher><subject>African Americans ; Age ; Analysis ; Antihypertensive drugs ; Antihypertensives ; Blood pressure ; Catheters ; Clinical trials ; Denervation ; Heart rate ; Hypertension ; Nervous system ; Obesity ; Patient compliance ; Patients ; Review ; Trends ; Ultrasonic imaging ; Veins &amp; arteries</subject><ispartof>International journal of hypertension, 2022-08, Vol.2022, p.1-12</ispartof><rights>Copyright © 2022 Hao Zhou et al.</rights><rights>COPYRIGHT 2022 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2022 Hao Zhou et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Hao Zhou et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c519t-a44747b5e152a3a3731cc76ced2133889fb62011013952dbe1ecdd59409fa8e53</citedby><cites>FETCH-LOGICAL-c519t-a44747b5e152a3a3731cc76ced2133889fb62011013952dbe1ecdd59409fa8e53</cites><orcidid>0000-0002-9563-7201 ; 0000-0001-9769-435X ; 0000-0002-0886-4511</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2704756745/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2704756745?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53770,53772,74873</link.rule.ids></links><search><contributor>Elia, Lanfranco D.</contributor><contributor>Lanfranco D Elia</contributor><creatorcontrib>Zhou, Hao</creatorcontrib><creatorcontrib>Xu, Yanping</creatorcontrib><creatorcontrib>Chen, Weijie</creatorcontrib><creatorcontrib>Wang, Liang</creatorcontrib><creatorcontrib>Du, Huaan</creatorcontrib><creatorcontrib>Liu, Hang</creatorcontrib><creatorcontrib>Ling, Zhiyu</creatorcontrib><creatorcontrib>Yin, Yuehui</creatorcontrib><title>Present Evidence of Determinants to Predict the Efficacy of Renal Denervation</title><title>International journal of hypertension</title><description>Sympathetic overactivation is one of the main contributors to development and progress of hypertension. Renal denervation (RDN) has been evidenced by series of clinical trials for its efficacy and safety to treat overactivated sympathetic nervous system induced diseases. However, the results were inconsistent and not all patients benefited from RDN. Appropriate patient selection and intraoperative factors to improve the efficacy of RDN need to be solved urgently. Over the decade, research studies on the correlations between indicators and the antihypertensive effects have been conducted and made a fairly well progress. Herein, we comprehensively reviewed the research studies on how to make RDN more predictable or improve the efficacy of RDN and summarized these potential indicators or devices which might be applied in clinical settings.</description><subject>African Americans</subject><subject>Age</subject><subject>Analysis</subject><subject>Antihypertensive drugs</subject><subject>Antihypertensives</subject><subject>Blood pressure</subject><subject>Catheters</subject><subject>Clinical trials</subject><subject>Denervation</subject><subject>Heart rate</subject><subject>Hypertension</subject><subject>Nervous system</subject><subject>Obesity</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Review</subject><subject>Trends</subject><subject>Ultrasonic imaging</subject><subject>Veins &amp; arteries</subject><issn>2090-0384</issn><issn>2090-0392</issn><issn>2090-0392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kl1rFDEUhgdRbFl75w8YEETQbfM5mdwIpa5aqCii1yGTnOxmmU1qkl3pvzfTXaorYhJIOHnOG86b0zTPMTrHmPMLggi54J1kmIhHzSlBEs0RleTxw7lnJ81ZzmtUB5V19U-bE8qlJATR0-bTlwQZQmkXO28hGGija99BgbTxQYeS2xLbylhvSltW0C6c80abu4n7CkGPlQ6Qdrr4GJ41T5weM5wd9lnz_f3i29XH-c3nD9dXlzdzw7Esc82YYGLggDnRVFNBsTGiM2AJprTvpRs6gjBGmEpO7AAYjLVcMiSd7oHTWXO917VRr9Vt8hud7lTUXt0HYloqnYo3IyjDkCGsd7IjPRO9HpDuBgGOMSSQFa5qvd1r3W6HDVhTzUh6PBI9vgl-pZZxpySVGEtaBV4dBFL8sYVc1MZnA-OoA8RtVkQgXutgrK_oi7_QddymauI9xQTvBOO_qaWuBfjgYn3XTKLqUmDGJcXVsllz_g-qTgsbb2IA52v8KOHlHwkr0GNZ5Thup4_Lx-CbPWhSzDmBezADIzW1nZraTh3aruKv9_jKB6t_-v_TvwDNr9D0</recordid><startdate>20220812</startdate><enddate>20220812</enddate><creator>Zhou, Hao</creator><creator>Xu, Yanping</creator><creator>Chen, Weijie</creator><creator>Wang, Liang</creator><creator>Du, Huaan</creator><creator>Liu, Hang</creator><creator>Ling, Zhiyu</creator><creator>Yin, Yuehui</creator><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9563-7201</orcidid><orcidid>https://orcid.org/0000-0001-9769-435X</orcidid><orcidid>https://orcid.org/0000-0002-0886-4511</orcidid></search><sort><creationdate>20220812</creationdate><title>Present Evidence of Determinants to Predict the Efficacy of Renal Denervation</title><author>Zhou, Hao ; Xu, Yanping ; Chen, Weijie ; Wang, Liang ; Du, Huaan ; Liu, Hang ; Ling, Zhiyu ; Yin, Yuehui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c519t-a44747b5e152a3a3731cc76ced2133889fb62011013952dbe1ecdd59409fa8e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>African Americans</topic><topic>Age</topic><topic>Analysis</topic><topic>Antihypertensive drugs</topic><topic>Antihypertensives</topic><topic>Blood pressure</topic><topic>Catheters</topic><topic>Clinical trials</topic><topic>Denervation</topic><topic>Heart rate</topic><topic>Hypertension</topic><topic>Nervous system</topic><topic>Obesity</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Review</topic><topic>Trends</topic><topic>Ultrasonic imaging</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Hao</creatorcontrib><creatorcontrib>Xu, Yanping</creatorcontrib><creatorcontrib>Chen, Weijie</creatorcontrib><creatorcontrib>Wang, Liang</creatorcontrib><creatorcontrib>Du, Huaan</creatorcontrib><creatorcontrib>Liu, Hang</creatorcontrib><creatorcontrib>Ling, Zhiyu</creatorcontrib><creatorcontrib>Yin, Yuehui</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Hao</au><au>Xu, Yanping</au><au>Chen, Weijie</au><au>Wang, Liang</au><au>Du, Huaan</au><au>Liu, Hang</au><au>Ling, Zhiyu</au><au>Yin, Yuehui</au><au>Elia, Lanfranco D.</au><au>Lanfranco D Elia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Present Evidence of Determinants to Predict the Efficacy of Renal Denervation</atitle><jtitle>International journal of hypertension</jtitle><date>2022-08-12</date><risdate>2022</risdate><volume>2022</volume><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>2090-0384</issn><issn>2090-0392</issn><eissn>2090-0392</eissn><abstract>Sympathetic overactivation is one of the main contributors to development and progress of hypertension. Renal denervation (RDN) has been evidenced by series of clinical trials for its efficacy and safety to treat overactivated sympathetic nervous system induced diseases. However, the results were inconsistent and not all patients benefited from RDN. Appropriate patient selection and intraoperative factors to improve the efficacy of RDN need to be solved urgently. Over the decade, research studies on the correlations between indicators and the antihypertensive effects have been conducted and made a fairly well progress. Herein, we comprehensively reviewed the research studies on how to make RDN more predictable or improve the efficacy of RDN and summarized these potential indicators or devices which might be applied in clinical settings.</abstract><cop>New York</cop><pub>Hindawi</pub><pmid>35992203</pmid><doi>10.1155/2022/5694127</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-9563-7201</orcidid><orcidid>https://orcid.org/0000-0001-9769-435X</orcidid><orcidid>https://orcid.org/0000-0002-0886-4511</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2090-0384
ispartof International journal of hypertension, 2022-08, Vol.2022, p.1-12
issn 2090-0384
2090-0392
2090-0392
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c40c248f9628478ab0a6b7ef44070d7f
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley Open Access; PubMed Central
subjects African Americans
Age
Analysis
Antihypertensive drugs
Antihypertensives
Blood pressure
Catheters
Clinical trials
Denervation
Heart rate
Hypertension
Nervous system
Obesity
Patient compliance
Patients
Review
Trends
Ultrasonic imaging
Veins & arteries
title Present Evidence of Determinants to Predict the Efficacy of Renal Denervation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A03%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Present%20Evidence%20of%20Determinants%20to%20Predict%20the%20Efficacy%20of%20Renal%20Denervation&rft.jtitle=International%20journal%20of%20hypertension&rft.au=Zhou,%20Hao&rft.date=2022-08-12&rft.volume=2022&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=2090-0384&rft.eissn=2090-0392&rft_id=info:doi/10.1155/2022/5694127&rft_dat=%3Cgale_doaj_%3EA714593137%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c519t-a44747b5e152a3a3731cc76ced2133889fb62011013952dbe1ecdd59409fa8e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2704756745&rft_id=info:pmid/35992203&rft_galeid=A714593137&rfr_iscdi=true